Synlett 2015; 26(06): 797-801
DOI: 10.1055/s-0034-1379980
letter
© Georg Thieme Verlag Stuttgart · New York

Synthesis of a C20-Deoxygenated Spirangien Derivative for Target Identification

Nadine Bluhm
a   Institute for Organic Chemistry and Center of Biomolecular Drug Research (BMWZ), Leibniz Universität Hannover, Schneiderberg 1B, 30167 Hannover, Germany   Email: Markus.Kalesse@oci.uni-hannnover.de
,
Markus Kalesse*
a   Institute for Organic Chemistry and Center of Biomolecular Drug Research (BMWZ), Leibniz Universität Hannover, Schneiderberg 1B, 30167 Hannover, Germany   Email: Markus.Kalesse@oci.uni-hannnover.de
b   Helmholtz Centre for Infection Research, Inhoffenstr. 7, 38124 Braunschweig, Germany
› Author Affiliations
Further Information

Publication History

Received: 18 October 2014

Accepted after revision: 17 December 2014

Publication Date:
03 February 2015 (online)


Preview

Abstract

The synthesis of a C20-deoxygenated spirangien derivative is described that allows the incorporation of various affinity labels for target identification of this potent natural product. The synthesis takes advantage of two major building blocks that can be accessed in 8 and 14 steps, respectively. The endgame joins both fragments through a selective aldol reaction and final protecting group manipulations furnish the target molecule.

Supporting Information